CAPTRUST Financial Advisors
PFE icon

CAPTRUST Financial Advisors’s Pfizer PFE Stock Holding History

CAPTRUST Financial Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,200
Closed -$40 – 2761
2023
Q3 		$40 Buy
+1,200
New +$42.4K ﹤0.01% 2608

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

CAPTRUST Financial Advisors's PFE Position: Q1 2026 in Review

CAPTRUST Financial Advisors increased its Pfizer (PFE) stake by 6.3% in Q1 2026, buying an estimated $5.52M and bringing the position to 3,485,448 shares worth $97.9M. The position accounts for 0.17% of the portfolio, ranked #116.

CAPTRUST Financial Advisors first reported a position in PFE in Q2 2017 and has held it in 36 quarters since. The position peaked at $158M in Q1 2025. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • CAPTRUST Financial Advisors held 3,485,448 shares of Pfizer worth $97.9M as of Q1 2026.
  • CAPTRUST Financial Advisors bought 207,374 Pfizer shares in Q1 2026, an estimated $5.52M.
  • Pfizer made up 0.17% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #116 holding.
  • CAPTRUST Financial Advisors first reported a position in Pfizer in Q2 2017 and has held it in 36 quarters since.
  • CAPTRUST Financial Advisors's Pfizer position peaked at $158M in Q1 2025.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.